文献速递腹部MR

磁共振成像在诊断合并肝细胞癌的LR-3与LR-4病灶中的价值

Value of magnetic resonance imaging for diagnosis of LR‑3 and LR-4 lesions coexisting with hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2024-06-05

本研究纳入102例肝细胞癌患者共110个LR-3和LR-4病灶,评估术前临床资料与常规MRI特征对合并病灶为肝细胞癌的预测价值。结果显示弥散受限、延迟强化及轻中度T2高信号为独立预测因子,三者联合预测肝细胞癌的特异度大于97%,AUC升至0.874。

要点

  • 弥散受限、延迟强化、轻中度T2高信号是合并LR-3/LR-4病灶为肝细胞癌的独立预测因子。
  • 三者联合预测肝细胞癌的特异度大于97%,AUC为0.874。
  • 弥散受限的OR为18.590,延迟强化的OR为0.113,轻中度T2高信号的OR为3.084。

核心结论

  • 弥散受限、延迟强化和轻中度T2高信号可作为肝细胞癌患者合并LR-3和LR-4病灶风险分层的有用特征。

研究设计与样本

  • 前瞻性临床试验(ChiCTR2000036201)纳入102例肝细胞癌患者(58.1±11.5岁,84.3%男性)合并110个LR-3和LR-4病灶,由两名放射科医师独立评估术前MRI特征并按LI-RADS分类,同时评估术前临床资料。

关键影像表现/征象

  • 弥散受限(OR:18.590,p<0.001)、延迟强化(OR:0.113,p<0.001)和轻中度T2高信号(OR:3.084,p=0.048)为肝细胞癌诊断的独立预测因子。
  • 上述独立变量的敏感度和特异度分别为66.7%至80.3%和56.8%至88.6%。
  • ROC分析显示,上述因素鉴别肝细胞癌的AUC分别为0.777、0.686和0.670。
  • 联合上述三项特征预测肝细胞癌的特异度大于97%,AUC进一步升至0.874。

诊断标准与关键数值

  • MRI特征按肝脏影像报告和数据系统(LI-RADS)分类,病灶为LR-3和LR-4。
  • 弥散受限诊断肝细胞癌的OR为18.590(p<0.001)。
  • 延迟强化诊断肝细胞癌的OR为0.113(p<0.001)。
  • 轻中度T2高信号诊断肝细胞癌的OR为3.084(p=0.048)。
  • 三项特征联合预测肝细胞癌的特异度大于97%,AUC为0.874。

临床应用与阅片要点

  • 在评估肝细胞癌患者合并的LR-3和LR-4病灶时,可关注弥散受限、延迟强化和轻中度T2高信号这三项MRI特征。
  • 三项特征联合应用时特异度大于97%,AUC为0.874,有助于风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To explore which preoperative clinical data and conventional magnetic resonance imaging (MRI) features may indicate the presence of hepatocellular carcinoma (HCC) in HCC patients coexisting with LR-3 and LR-4 lesions.

METHODS: HCC Patients coexisting with LR-3 and LR-4 lesions who participated in a prospective clinical trial (XX) were included in this study. Two radiologists independently assessed the preoperative MRI features and each lesion was assigned according to the liver imaging reporting and data system (LI-RADS). The preoperative clinical data were also evaluated. The relative values of these parameters were assessed as potential predictors of HCC for coexisting LR-3 and LR-4 lesions.

RESULTS: We enrolled 102 HCC patients (58.1 ± 11.5 years; 84.3% males) coexisting with 110 LR-3 and LR-4 lesions (HCCs group [n = 66]; non-HCCs group [n = 44]). The presence of restricted diffusion (OR: 18.590, p < 0.001), delayed enhancement (OR: 0.113, p < 0.001), and mild-moderate T2 hyperintensity (OR: 3.084, p = 0.048) were found to be independent predictors of HCC diagnosis. The sensitivity and specificity of the above independent variables for the diagnosis of HCC ranged from 66.7 to 80.3% and 56.8 to 88.6%, respectively. ROC analysis showed that, in discriminating HCC, the AUCs of the above factors were 0.777, 0.686, and 0.670, respectively. Combining these three findings for the prediction of HCC resulted in a specificity greater than 97%, and the AUC further increased to 0.874.

CONCLUSION: The presence of restricted diffusion, delayed enhancement, and mild-moderate T2 hyperintensity can be useful features for risk stratification of coexisting LR-3 and LR-4 lesions in HCC patients. Trial registration a prospective clinical trial (ChiCTR2000036201).

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Liu Y, Xiao Y, Ni X, et al. Value of magnetic resonance imaging for diagnosis of LR‑3 and LR-4 lesions coexisting with hepatocellular carcinoma. Abdom Radiol (NY). 2024. PMID: 38834779. doi:10.1007/s00261-024-04338-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。